Maloney B

References (3)

Title : Rivastigmine modifies the alpha-secretase pathway and potentially early Alzheimer's disease - Ray_2020_Transl.Psychiatry_10_47
Author(s) : Ray B , Maloney B , Sambamurti K , Karnati HK , Nelson PT , Greig NH , Lahiri DK
Ref : Transl Psychiatry , 10 :47 , 2020
Abstract :
PubMedSearch : Ray_2020_Transl.Psychiatry_10_47
PubMedID: 32066688

Title : The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice - Lahiri_2007_J.Pharmacol.Exp.Ther_320_386
Author(s) : Lahiri DK , Chen D , Maloney B , Holloway HW , Yu QS , Utsuki T , Giordano T , Sambamurti K , Greig NH
Ref : Journal of Pharmacology & Experimental Therapeutics , 320 :386 , 2007
Abstract :
PubMedSearch : Lahiri_2007_J.Pharmacol.Exp.Ther_320_386
PubMedID: 17003227

Title : High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression - Sokol_2006_J.Child.Neurol_21_444
Author(s) : Sokol DK , Chen D , Farlow MR , Dunn DW , Maloney B , Zimmer JA , Lahiri DK
Ref : Journal of Child Neurology , 21 :444 , 2006
Abstract :
PubMedSearch : Sokol_2006_J.Child.Neurol_21_444
PubMedID: 16948926